Lobbying

Neurocytonix's latest lobbying report covers Q3 2024, at $30K. Its first report covers Q2 2024; the issues it reports most are Defense and Medical/Disease Research/Clinical Labs.

Neurocytonix

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q2 2024
The first quarter a report named it

Lobbying by quarter

Neurocytonix lobbying by quarter
Neurocytonix lobbying by quarter
QuarterAmountReports
Q2 2024$30K1
Q3 2024$30K1
Q4 2024$00
Q1 2025$00
Q2 2025$00
Q3 2025$00
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Defense$20K · 2 reports
  • Medical research and clinical labs$20K · 2 reports
  • Veterans$20K · 2 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • Defense, Dept of (DOD)2 reports
  • HOUSE OF REPRESENTATIVES2 reports
  • SENATE2 reports
  • Veterans Affairs, Dept of (VA)2 reports
  • Veterans Employment & Training Service2 reports

Firms it paid

Firm
Steptoe$60K2 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

Filed by
24/11/14for Q3 2024Steptoe$30K
24/10/21for Q3 2024Steptoe$30K
24/07/22for Q2 2024Steptoe$30K
24/05/10for Q2 2024SteptoeUnder $5,000